Investment Rating - The investment rating for the company is "Buy" (maintained) [5] Core Views - The company demonstrates long-term growth potential through high dividends and overseas expansion [5] - Significant improvement in Q2 profits and a high dividend payout ratio highlight the investment value [6] - The company has a robust order growth, particularly in overseas markets, which is expected to drive profitability [6] Financial Performance Summary - In H1 2025, the company achieved revenue of 9.339 billion yuan, a year-on-year decrease of 5.86%, while net profit attributable to shareholders was 328 million yuan, reflecting a year-on-year increase of 1.69% [6] - The company plans to distribute a cash dividend of 170 million yuan in H1 2025, with a dividend payout ratio of 51.82% [6] - The company’s gross margin for H1 2025 was 15.75%, with a net profit margin of 4.02% [6] Revenue and Profit Forecast - The company is expected to achieve net profits of 683 million yuan, 737 million yuan, and 798 million yuan for the years 2025, 2026, and 2027 respectively, with year-on-year growth rates of 7.06%, 7.97%, and 8.25% [7][8] - The projected P/E ratios for 2025, 2026, and 2027 are 12.51, 11.59, and 10.71 respectively [7] Market Performance - The company’s construction decoration segment reported revenue of 8.761 billion yuan in H1 2025, a decrease of 6.52% year-on-year, while the healthcare segment grew by 5.36% to 578 million yuan [6] - The company has established sales teams in Europe and the Americas, leading to a significant increase in overseas orders, which accounted for 38% of total orders in H1 2025 [6] Order and Margin Analysis - The total amount of bids won in H1 2025 was approximately 13.7 billion yuan, a year-on-year increase of 6.29% [6] - The company’s gross margin improved slightly, with a Q2 gross margin of 16.34%, up 0.85 percentage points year-on-year [6]
江河集团(601886):高分红与海外布局共塑长期成长性